Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sanger Sequencing

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-ancestry gene expression models amplify transcriptome-wide association study discovery and validation.

Nature communications·2026

Same author

Increased Arrhythmic Risk in Obesity Is Transduced by Adipose Tissue-Derived Extracellular Vesicles.

JACC. Basic to translational science·2026

Same author

Genetically predicted cytotrophoblast gene expression is associated with birth weight and adult body mass index.

Placenta·2026

Same author

Response of an Infant With Presumed Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) to Ketone Supplementation.

American journal of medical genetics. Part A·2026

Same author

Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction.

Circulation·2026

Same author

Proteogenomic Analysis of Coronary Artery Calcification in Human Populations.

Arteriosclerosis, thrombosis, and vascular biology·2026

Search research articles

Related Experiment Video

Updated: May 16, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

An exponential combination procedure for set-based association tests in sequencing studies.

Lin S Chen¹, Li Hsu, Eric R Gamazon

¹Department of Health Studies, The University of Chicago, Chicago, IL 60637, USA. lchen@health.bsd.uchicago.edu

American Journal of Human Genetics

|November 20, 2012

Summary

This study introduces a novel gene-based test using the sum of exponential variant statistics for enhanced genetic association analysis. This method improves the detection of sparse genetic risk factors, offering new insights into complex diseases.

More Related Videos

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Related Experiment Videos

Last Updated: May 16, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Area of Science:

Genomics and Bioinformatics
Statistical Genetics
Pharmacogenomics

Background:

Next-generation sequencing (NGS) enables comprehensive human genome analysis, including common and rare variants.
Identifying genetic factors for disease risk and complex phenotypes often involves analyzing sets of variants within genes.
Existing set-based methods typically sum variant statistics, but may lack power for sparse genetic signals.

Purpose of the Study:

To propose a novel set-based association testing method using the summation of the exponential of variant statistics.
To provide theoretical justification (Bayesian and frequentist) for the proposed method's power in detecting sparse genetic associations.
To apply the new method to a real-world dataset for uncovering genetic insights in anticancer pharmacogenomics.

Main Methods:

Developed a gene-based test utilizing the sum of the exponential of variant statistics for set association analysis.
Provided theoretical underpinnings from Bayesian and frequentist viewpoints to support the method's efficacy.
Applied the exponential combination gene-based test to NGS data from a pharmacogenomics study.

Main Results:

The proposed method demonstrates superior power for sparse alternatives, where only a few variants in a set are associated with the phenotype.
Application to anticancer pharmacogenomics data identified significant genes and pathways related to drug susceptibility.
Uncovered mechanistic insights into chemotherapeutic response in cancer patients.

Conclusions:

The exponential combination gene-based test offers a powerful new approach for genetic association studies, particularly for sparse genetic architectures.
This method enhances the ability to detect genetic risk factors and understand complex phenotypes.
The findings provide valuable mechanistic insights for anticancer drug development and personalized medicine.